{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:50:25Z","timestamp":1776329425808,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.oftal.2016.12.009","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T18:15:17Z","timestamp":1486232117000},"page":"210-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Determinaci\u00f3n de mediadores de la respuesta inmune e inflamaci\u00f3n en l\u00e1grimas: cambios en ojo seco y glaucoma frente a poblaci\u00f3n sana"],"prefix":"10.1016","volume":"92","author":[{"given":"J.","family":"Benitez-del-Castillo S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Morillo-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Galbis-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Pinazo-Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.oftal.2016.12.009_bib0210","first-page":"S79","article-title":"Dry eye disease: Pathophysiology, classification, and diagnosis","volume":"14","author":"Perry","year":"2008","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.oftal.2016.12.009_bib0215","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/08820538.2010.488568","article-title":"Dry eye disease","volume":"25","author":"Tavares","year":"2010","journal-title":"Semin Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0220","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0181-5512(07)89557-X","article-title":"Ocular surface investigations in dry eye","volume":"30","author":"Labb\u00e9","year":"2007","journal-title":"J Fr Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0225","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open-angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.oftal.2016.12.009_bib0230","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/archopht.118.6.819","article-title":"Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study","volume":"118","author":"Munoz","year":"2000","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0235","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0240","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0245","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/01.ico.0000220776.93852.d9","article-title":"Incidence and prevalence of glaucoma in severe ocular surface disease","volume":"25","author":"Tsai","year":"2006","journal-title":"Cornea."},{"key":"10.1016\/j.oftal.2016.12.009_bib0250","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma."},{"key":"10.1016\/j.oftal.2016.12.009_bib0255","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17925\/EOR.2013.07.01.31","article-title":"Ocular surface morbidities in glaucoma","volume":"7","author":"Benitez-del-Castillo","year":"2013","journal-title":"Eur Ophthal Rev"},{"key":"10.1016\/j.oftal.2016.12.009_bib0260","first-page":"785","article-title":"Patient satisfaction with glaucoma therapy: Reality or myth?","volume":"9","author":"Lemij","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftal.2016.12.009_bib0265","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: Human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2016.12.009_bib0270","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.oftal.2016.12.009_bib0275","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1242\/jcs.097683","article-title":"Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration","volume":"125","author":"Suzuki","year":"2012","journal-title":"J Cell Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0280","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.exer.2005.10.018","article-title":"Effect of inflammation on lacrimal gland function","volume":"82","author":"Zoukhri","year":"2006","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftal.2016.12.009_bib0285","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","article-title":"Inflammatory mediators in the elderly","volume":"39","author":"Krabbe","year":"2004","journal-title":"Exp Gerontol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0290","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"An immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0295","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ophtha.2012.07.008","article-title":"Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2016.12.009_bib0300","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1007\/s00417-012-2151-0","article-title":"Outer retinal tubulations in chronic central serous chorioretinopathy","volume":"251","author":"Gallego-Pinazo","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0305","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0310","series-title":"Clinical decisions in glaucoma","first-page":"52","author":"Hodapp","year":"1993"},{"key":"10.1016\/j.oftal.2016.12.009_bib0315","first-page":"6215745","article-title":"Eclectic ocular comorbidities and systemic diseases with eye involvement: A review","volume":"2016","author":"Pinazo-Dur\u00e1n","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.oftal.2016.12.009_bib0320","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/CIA.S40640","article-title":"Effects of a nutraceutical formulation based on the combination of antioxidants and \u03c9-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders","volume":"8","author":"Pinazo-Dur\u00e1n","year":"2013","journal-title":"Clin Interv Aging."},{"key":"10.1016\/j.oftal.2016.12.009_bib0325","first-page":"711","article-title":"Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids","volume":"8","author":"Galbis-Estrada","year":"2013","journal-title":"Clin Interv Aging."},{"key":"10.1016\/j.oftal.2016.12.009_bib0330","first-page":"2400","article-title":"IL-6 induction in desiccated corneal epithelium in vitro and in vivo","volume":"17","author":"Higuchi","year":"2011","journal-title":"Mol Vis."},{"key":"10.1016\/j.oftal.2016.12.009_bib0335","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enr\u00edquez-de-Salamanca","year":"2010","journal-title":"Mol Vis."},{"key":"10.1016\/j.oftal.2016.12.009_bib0340","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest."},{"key":"10.1016\/j.oftal.2016.12.009_bib0345","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/exer.2001.0999","article-title":"Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs. corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK","volume":"72","author":"Tuominen","year":"2001","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftal.2016.12.009_bib0350","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1167\/iovs.11-7266","article-title":"Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays","volume":"52","author":"Boehm","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0355","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.oftal.2016.12.009_bib0360","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0365","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0370","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1167\/iovs.11-9417","article-title":"Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease","volume":"53","author":"Na","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0375","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/sj.eye.6701811","article-title":"Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis","volume":"20","author":"Abu El-Asrar","year":"2006","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.oftal.2016.12.009_bib0380","doi-asserted-by":"publisher","first-page":"129873","DOI":"10.1155\/2008\/129873","article-title":"Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: Prospects for therapeutic intervention","volume":"2008","author":"Yoo","year":"2008","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.oftal.2016.12.009_bib0385","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2015.11.016","article-title":"Inflammatory cytokines regulate secretion of VEGF and chemokines by human conjunctival fibroblasts: Role in dysfunctional tear syndrome","volume":"78","author":"Nagineni","year":"2016","journal-title":"Cytokine."},{"key":"10.1016\/j.oftal.2016.12.009_bib0390","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"Baudouin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2016.12.009_bib0395","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1167\/iovs.10-6532","article-title":"Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication","volume":"52","author":"Wong","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftal.2016.12.009_bib0400","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.exer.2015.06.032","article-title":"FTY720 ameliorates dry eye disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue","volume":"138","author":"Xiao","year":"2015","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftal.2016.12.009_bib0405","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1167\/iovs.14-16153","article-title":"Effect of topical 5-aminoimidazole-4-carboxamide-1-(-d-ribofuranoside in a mouse model of experimental dry eye","volume":"56","author":"Sung","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.oftal.2016.12.009_bib0410","first-page":"177","article-title":"Analysis of tear inflammatory mediators: A comparison between the microarray and Luminex methods","volume":"22","author":"Dionne","year":"2016","journal-title":"Mol Vis."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117300114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117300114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T10:53:27Z","timestamp":1536058407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669117300114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0365669117300114"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2016.12.009","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinaci\u00f3n de mediadores de la respuesta inmune e inflamaci\u00f3n en l\u00e1grimas: cambios en ojo seco y glaucoma frente a poblaci\u00f3n sana","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2016.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}